Source: Annals of the rheumatic diseases. Unidade: FM
Subjects: ANTICORPOS MONOCLONAIS, DOENÇAS DO TESTÍCULO EM ANIMAL, RESULTADO DE TRATAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ELHAI, Muriel et al. Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study. Annals of the rheumatic diseases, v. 78, n. 7, p. 979-987, 2019Tradução . . Disponível em: https://doi.org/10.1136/annrheumdis-2018-214816. Acesso em: 03 nov. 2024.APA
Elhai, M., Boubaya, M., Distler, O., Smith, V., Matucci-Cerinic, M., Sancho, J. J. A., et al. (2019). Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study. Annals of the rheumatic diseases, 78( 7), 979-987. doi:10.1136/annrheumdis-2018-214816NLM
Elhai M, Boubaya M, Distler O, Smith V, Matucci-Cerinic M, Sancho JJA, Truchetet M-E, Braun-moscovici Y, Iannone F, Yoshinari NH. Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study [Internet]. Annals of the rheumatic diseases. 2019 ; 78( 7): 979-987.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1136/annrheumdis-2018-214816Vancouver
Elhai M, Boubaya M, Distler O, Smith V, Matucci-Cerinic M, Sancho JJA, Truchetet M-E, Braun-moscovici Y, Iannone F, Yoshinari NH. Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study [Internet]. Annals of the rheumatic diseases. 2019 ; 78( 7): 979-987.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1136/annrheumdis-2018-214816
